Wird geladen...
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
BACKGROUND: The combination of gemcitabine and docetaxel (GT) has been demonstrated to be effective against various types of solid tumors, including sarcoma. However, the regimen has not been confirmed in large, well-designed clinical trials in refractory metastatic osteosarcoma. METHODS: We retrosp...
Gespeichert in:
| Veröffentlicht in: | BMC Cancer |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192345/ https://ncbi.nlm.nih.gov/pubmed/30326879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4872-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|